Sort   by:  
 Page size 
UnknownEngaging communities in addressing air quality: a scoping review.
Not available
S-EPMC9484248 | biostudies-literature
UnknownFour-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
Not available
S-EPMC8282329 | biostudies-literature
UnknownRisk-stratified treatment for drug-susceptible pulmonary tuberculosis.
Not available
S-EPMC11526018 | biostudies-literature
UnknownPost-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trial.
Not available
S-EPMC11381616 | biostudies-literature
UnknownSafety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Not available
S-EPMC10150320 | biostudies-literature
UnknownEffectiveness of Iodophor vs Chlorhexidine Solutions for Surgical Site Infections and Unplanned Reoperations for Patients Who Underwent Fracture Repair: The PREP-IT Master Protocol.
Not available
S-EPMC7139274 | biostudies-literature
UnknownPragmatic randomized trial evaluating pre-operative aqueous antiseptic skin solution in open fractures (Aqueous-PREP): the feasibility of a cluster randomized crossover study.
Not available
S-EPMC7919062 | biostudies-literature
UnknownAssociation of COVID-19 With Achieving Time-to-Surgery Benchmarks in Patients With Musculoskeletal Trauma.
Not available
S-EPMC8727030 | biostudies-literature
UnknownContinuous vs Intermittent β-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial.
Not available
S-EPMC11170452 | biostudies-literature
UnknownManaging work flow in high enrolling trials: The development and implementation of a sampling strategy in the PREPARE trial.
Not available
S-EPMC7873628 | biostudies-literature
Sort   by:  
 Page size